Inaktiver Wert
Sektor Caplin Point Laboratories Ltd NSE India S.E.
Aktien
INE475E01018
Pharmazeutika
|
Schlusskurs
NSE India S.E.
|
||
| - INR | - |
|
| 14.08. | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 12.08. | Caplin Point Laboratories Limited legt Ergebnisse für das erste Quartal zum 30. Juni 2026 vor | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.89% | -1.09% | -2.11% | +6.55% | +10.43% | +19.16% | +67.77% | +140.56% | +142.73% | 48.26 Mrd. | |
| -1.72% | -1.15% | +1.91% | +13.71% | +35.58% | +45.80% | +117.34% | +144.61% | +164.92% | 40.5 Mrd. | |
| -0.70% | -2.70% | -5.06% | -1.16% | -8.36% | -10.84% | +11.79% | +47.17% | +139.64% | 11.85 Mrd. | |
| -2.01% | -5.96% | -0.10% | +2.85% | +22.49% | +10.47% | +76.64% | +101.57% | +191.25% | 11.83 Mrd. | |
| +2.31% | 0.00% | +1.72% | +4.31% | +31.03% | +26.67% | +153.33% | +136.44% | +347.06% | 9.36 Mrd. | |
| +0.08% | -4.11% | +5.86% | +7.55% | +29.95% | +24.83% | +43.80% | +45.02% | +124.72% | 7.5 Mrd. | |
| -1.67% | -0.35% | +6.41% | +10.04% | +12.70% | +41.04% | -11.59% | -10.83% | -7.90% | 7.37 Mrd. | |
| -0.89% | -3.09% | +7.89% | +12.51% | +19.75% | +18.78% | +207.82% | +356.62% | +190.63% | 7.28 Mrd. | |
| -0.16% | -2.36% | -8.53% | -2.66% | -36.59% | -46.14% | +16.28% | +17.28% | +11.66% | 5.19 Mrd. | |
| -1.60% | -2.59% | +0.79% | +16.41% | +25.13% | +32.54% | +102.62% | +134.78% | +169.77% | 4.58 Mrd. | |
| -2.60% | -5.19% | +1.79% | +3.93% | +28.80% | +44.74% | -8.91% | -23.26% | -57.74% | 4.19 Mrd. | |
| -1.19% | +2.92% | -3.96% | +17.83% | -2.84% | -18.33% | +87.58% | +51.24% | - | 3.81 Mrd. | |
| +7.08% | +5.64% | +4.12% | +8.74% | +44.43% | +41.24% | +756.02% | +396.31% | +155.67% | 3.59 Mrd. | |
| -0.15% | -4.81% | -2.04% | -0.37% | -5.01% | -5.14% | +46.30% | +205.91% | +728.31% | 2.87 Mrd. | |
| -2.55% | -4.05% | +2.24% | +6.66% | -17.81% | -30.40% | +49.25% | +81.29% | +9.17% | 2.75 Mrd. | |
| +1.03% | -8.19% | -5.76% | -46.23% | -32.47% | -21.50% | +68.45% | +191.82% | +1’599.13% | 2.73 Mrd. | |
| 0.00% | -1.22% | -3.38% | -12.16% | -3.58% | -10.56% | +15.88% | - | - | 2.56 Mrd. | |
| +0.29% | -5.14% | -12.59% | -9.49% | -10.59% | -1.89% | +41.33% | +10.39% | +52.72% | 2.45 Mrd. | |
| -2.76% | -4.12% | -1.74% | -5.30% | +6.08% | -46.64% | +77.06% | +55.55% | - | 2.38 Mrd. | |
| Durchschnitt | -0.43% | -2.15% | -0.66% | +1.77% | +7.85% | +5.99% | +100.99% | +115.69% | +247.61% | 9.53 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -0.83% | -1.75% | -0.07% | +6.38% | +15.94% | +19.48% | +91.74% | +124.70% | +178.54% |
- Börse
- Aktien
- A2DSTM Aktie
- Aktie
- Sektor Caplin Point Laboratories Ltd
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
